title: A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.
abstract: The current strategy for identifying the carcinogenicity of drugs involves the 2-year bioassay in male and female rats and mice. As this assay is cost-intensive and time-consuming there is a high interest in developing approaches for the screening and prioritization of drug candidates in preclinical safety evaluations. Predictive models based on toxicogenomics investigations after short-term exposure have shown their potential for assessing the carcinogenic risk. In this study, we investigated a novel method for the evaluation of toxicogenomics data based on ensemble feature selection in conjunction with bootstrapping for the purpose to derive reproducible and characteristic multi-gene signatures. This method was evaluated on a microarray dataset containing global gene expression data from liver samples of both male and female mice. The dataset was generated by the IMI MARCAR consortium and included gene expression profiles of genotoxic and nongenotoxic hepatocarcinogens obtained after treatment of CD-1 mice for 3 or 14 days. We developed predictive models based on gene expression data of both sexes and the models were employed for predicting the carcinogenic class of diverse compounds. Comparing the predictivity of our multi-gene signatures against signatures from literature, we demonstrated that by incorporating our gene sets as features slightly higher accuracy is on average achieved by a representative set of state-of-the art supervised learning methods. The constructed models were also used for the classification of Cyproterone acetate (CPA), Wy-14643 (WY) and Thioacetamid (TAA), whose primary mechanism of carcinogenicity is controversially discussed. Based on the extracted mouse liver gene expression patterns, CPA would be predicted as a nongenotoxic compound. In contrast, both WY and TAA would be classified as genotoxic mouse hepatocarcinogens.
authors.affiliation: Center for Bioinformatics Tuebingen (ZBIT), University of Tuebingen, Tübingen, Germany.
authors.forename: Johannes
authors.initials: J
authors.lastname: Eichner
authors.forename: Nadine
authors.initials: N
authors.lastname: Kossler
authors.forename: Clemens
authors.initials: C
authors.lastname: Wrzodek
authors.forename: Arno
authors.initials: A
authors.lastname: Kalkuhl
authors.forename: Dorthe
authors.initials: D
authors.lastname: Bach Toft
authors.forename: Nina
authors.initials: N
authors.lastname: Ostenfeldt
authors.forename: Virgile
authors.initials: V
authors.lastname: Richard
authors.forename: Andreas
authors.initials: A
authors.lastname: Zell
mesh_terms: D000818:Animals; D015197:Carcinogenicity Tests / Q000379:methods; D002273:Carcinogens / Q000737:chemistry / Q000145:classification / Q000633:toxicity*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects* / Q000235:genetics*; D016000:Cluster Analysis; D005260:Female; D020869:Gene Expression Profiling; D008114:Liver Neoplasms, Experimental / Q000235:genetics*; D008297:Male; D051379:Mice; D015203:Reproducibility of Results; D043922:Toxicogenetics / Q000379:methods*
chemical_list: D002273:Carcinogens
references.citation: Toxicology. 2008 Aug 19;250(1):15-26
references.pmid: 18619722
references.citation: Carcinogenesis. 2009 Oct;30(10):1805-12
references.pmid: 19696161
references.citation: Toxicol Appl Pharmacol. 2010 Mar 15;243(3):300-14
references.pmid: 20004213
references.citation: Nucleic Acids Res. 2003 Feb 15;31(4):e15
references.pmid: 12582260
references.citation: Mol Nutr Food Res. 2010 Feb;54(2):218-27
references.pmid: 20041446
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72
references.pmid: 12011421
references.citation: Mutat Res. 1979 Aug;67(4):361-5
references.pmid: 384238
references.citation: Mol Carcinog. 2006 Dec;45(12):914-33
references.pmid: 16921489
references.citation: Mutat Res. 1987 Oct;192(2):141-3
references.pmid: 3657843
references.citation: Arch Toxicol. 2011 Dec;85(12):1627-40
references.pmid: 21607683
references.citation: Cancer Res. 1999 Oct 1;59(19):4759-60
references.pmid: 10519378
references.citation: Toxicology. 2008 Apr 3;246(1):2-8
references.pmid: 18006136
references.citation: Comput Biol Chem. 2010 Aug;34(4):215-25
references.pmid: 20702140
references.citation: Carcinogenesis. 1996 Mar;17(3):551-4
references.pmid: 8631143
references.citation: Chem Res Toxicol. 2011 Jul 18;24(7):1062-70
references.pmid: 21627106
references.citation: Mutat Res. 2006 Sep 19;608(1):29-42
references.pmid: 16769241
references.citation: Mutagenesis. 2001 Sep;16(5):439-42
references.pmid: 11507244
references.citation: Mutat Res. 1994 Aug;322(2):142-4
references.pmid: 7519322
references.citation: Toxicol Sci. 2007 Sep;99(1):90-100
references.pmid: 17557906
references.citation: Bioinformatics. 2010 Sep 15;26(18):i554-60
references.pmid: 20823321
references.citation: Hepatology. 2012 Jan;55(1):121-31
references.pmid: 21898503
references.citation: Toxicol Pathol. 2001;29 Suppl:117-27
references.pmid: 11695547
references.citation: Cancer Res. 1986 Sep;46(9):4601-6
references.pmid: 2873887
references.citation: Mutat Res. 2008 Jan 1;637(1-2):23-39
references.pmid: 17689568
references.citation: Toxicol Sci. 2005 Jun;85(2):747-808
references.pmid: 15800034
references.citation: Mutat Res. 2010 Apr 30;698(1-2):30-7
references.pmid: 20188853
references.citation: Bioinformatics. 2009 Feb 1;25(3):415-6
references.pmid: 19106121
references.citation: Mutat Res. 2010 Dec;705(3):184-200
references.pmid: 20399889
references.citation: Mutat Res. 2009 Sep-Dec;682(2-3):94-109
references.pmid: 19631282
references.citation: Genome Biol. 2004;5(10):R80
references.pmid: 15461798
references.citation: Chem Rev. 2013 May 8;113(5):2940-57
references.pmid: 23469814
references.citation: Bioinformatics. 2010 Feb 1;26(3):392-8
references.pmid: 19942583
references.citation: Science. 1999 Oct 15;286(5439):531-7
references.pmid: 10521349
references.citation: Cancer Res. 1989 Jun 15;49(12):3246-51
references.pmid: 2566380
references.citation: Toxicol Sci. 2011 Mar;120 Suppl 1:S225-37
references.pmid: 21177775
references.citation: Toxicol Appl Pharmacol. 2011 Sep 15;255(3):297-306
references.pmid: 21784091